Member Info for Sixthavenue

Does Bode well , Sar got Government funding to carry out tests and trials of their WW patented compound - they are still in the analysis stage .
Read the script

https://podio.com/webforms/24960299/1831874

This could leap like a frog on Monday regardless of the SRA 737 status

Anyone think the 50 k Buyer is now nibling up at 10/15/25 k buys - very consistant

You sound like the bear from Rainbow - Bungle

Can someone say in a simple yes or no - Will the US tax credit note be available to the RTO candidate ?

What Boaby said for what it's worth

The answer is nothing other than the name Motif and that's not really an asset ,so they have no assets, the tax loss is credited to Mofif inc in America so no tax claim on any loss, they have no money in the bank, vertually broke.......

Also note they have a California office . I know someone mentioned that possible tax credits were only covered by the US branch of Motif inc and could only be transferred to a US interest .
Could this also be significant ?

Last Chance to put your order in

Can't help but thinking mega buys are about to come in - just my take

" burned out old kamikazi jet " - Produces - " A Phoenix rising from the ashes "

It's like when you were small and yer Ma bought you a lucky bag and you didn't know what was inside ??

Goldilocks only out now is to throw 5 Kings on the table . ??????

There is much in the world today , just let the BOD manage the detail without the constant pressing , I am sure they will make every effort to produce the best results for all of us - and them .
Reminds me of my old jotter message in primary school in the early 60's .
" Better a moment at the kerb - than 6 months in Hospital "

That is very significant and hint strongly of much greater things to come ,

Playing a game of 3 card brag in a North London pub with Chelsea supporters

Promising and great to be given an update

No worrying from me , just trying to figure what they are obligated to report

The Company no longer has control of Motif BioSciences Inc. but does retain a contractual interest ( what are the details of that agreement ? ) in any upside in consideration ( What is the agreed minimum value to Hercules ? ) , above what is owed to Hercules Capital Inc. ("Hercules") What was that ? ( The sum that allowed the outstanding charge to be satisfied ) - , at the time of monetisation, should the iclaprim asset be monetised by Hercules. To date, the Subsidiary and Hercules have been unsuccessful in monetising the iclaprim asset ( If patents are subsequently being registered , does this mean a sale or agreement of the IP has taken place ? and Motif still having a vested financial interest would / should they be obliged to disclose to it's shareholders and the wider market ) , and it is not clear when or if they will be able to do so. If there is a monetisation of the iclaprim asset, it is also unclear if there would be any residual available to the Company's shareholders above what Hercules will be owed at that time

Who bought IP of Iclaprim? , Still advertised for sale on Tamarak CEO linkedin , Was there a transfe